| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| bendamustine moa | 1.23 | 0.7 | 8817 | 44 | 16 |
| bendamustine | 0.18 | 0.6 | 7938 | 67 | 12 |
| moa | 1.68 | 0.9 | 10 | 57 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| bendamustine moa | 1.42 | 0.3 | 6051 | 56 |
| bendamustine macmillan | 1.51 | 0.4 | 1952 | 43 |
| bendamustine manufacturer | 1.65 | 1 | 899 | 50 |
| bendamustine maroc | 1.41 | 0.8 | 8567 | 56 |
| bendamustine monographie | 1.5 | 0.1 | 9078 | 69 |
| bendamustine mode of action | 0.3 | 0.4 | 8298 | 76 |
| bendamustine monograph canada | 0.49 | 0.6 | 4243 | 17 |
| bendamustine mantle cell lymphoma | 0.61 | 1 | 214 | 2 |
| bendamustine macmillan info | 0.69 | 0.6 | 7866 | 29 |
| bendamustine and rituximab macmillan | 1.44 | 0.3 | 1656 | 93 |
| rituximab bendamustine macmillan | 1.33 | 0.9 | 1904 | 73 |
| r bendamustine macmillan | 1.04 | 0.5 | 5247 | 31 |
| polatuzumab bendamustine rituximab macmillan | 1.59 | 0.2 | 81 | 48 |
| macmillan bendamustine patient information | 1.44 | 0.8 | 1862 | 61 |
